Local renin-angiotensin II systems, angiotensin-converting enzyme and its homologue ACE2: Their potential role in the pathogenesis of chronic obstructive pulmonary diseases, pulmonary hypertension and acute respiratory distress syndrome

Current Medicinal Chemistry

Volumn 18, Issue 23, 2011, Pages 3506-3515

  Kaparianos, A ^a   Argyropoulou, E ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

ACE; ACE2; Angiotensin II; Asthma; COPD; Pulmonary hypertension

Indexed keywords

ANGIOTENSIN II; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT RESPIRATORY DISTRESS SYNDROME; AIRWAY REMODELING; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORONAVIRUS; CYTOKINE RELEASE; DISEASE PREDISPOSITION; DISEASE SEVERITY; DNA POLYMORPHISM; ERYTHROCYTOSIS; GENE; HUMAN; INFLAMMATION; INFLAMMATORY CELL; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PULMONARY HYPERTENSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASODILATATION;

ANGIOTENSIN II; HUMANS; HYPERTENSION, PULMONARY; PEPTIDYL-DIPEPTIDASE A; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RENIN-ANGIOTENSIN SYSTEM; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 80052001034     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986711796642562     Document Type: Article

References (184)

1. Danser AHJ. Local renin-angiotensin systems. Mol. Cell. Biochem. 1996, 157, 211-216. (Pubitemid 26142454)
2. Saito, Y; Berk, B.C. Angiotensin II-mediated signal transduction pathways. Curr. Hypertens. Rep. 2002, 4, L167-L171.
3. Touyz, RM. Reactive oxygen species as mediators of calcium signaling by angiotensin II: implications in vascular physiology and pathophysiology. Antiox. Redox. Signal 2005, 7, 1302-1314. (Pubitemid 41232528)
4. Marshall, R.P. The pulmonary renin-angiotensin system. Curr. Pharm. Des. 2003, 9, 715-722. (Pubitemid 36367593)
5. Marshall, R.P.; Gohlke, P.; Chambers, R.C.; Howell, D.C.; Bottoms, S.E.; Unger, T.; McAnulty, R.J.; Laurent, G.J. Angiotensin II and fibroproliferative response to acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 2004, 286, L156-L164. (Pubitemid 38055871)
6. DeGasparo, M.; Catt, K.J.; Inagami, T.; Wright, J.W.; Unger, T. International Union of Pharmacology XXIII. The angiotensin II receptors. Pharmacol. Rev. 2000, 52, 415-472.
7. Cassis, L.; Shenoy, U.; Lipke, D.; Baughn, J.; Fettinger, M.; Gillespie, M. Lung angiotensin receptor binding characteristics during the development of monocrotaline-induced pulmonary hypertension. Biochem. Pharmacol. 1997, 54, 27-31. (Pubitemid 27353219)
8. Campbell, D.J.; Habener, J.F. Hybridization in situ studies of angiotensinogen gene expression in rat adrenal and lung. Endocrinology 1989, 124, 218-222. (Pubitemid 19033649)
9. Entzeroth, M.; Hadamovsky, S. Angiotensin II receptors in the rat lung are of the AII-1 subtype. Eur. J. Pharmacol. 1991, 206, 237-241.
10. Schulman, I.H.; Raij, L. The angiotensin II type 2 receptor: what is its clinical significance? Curr. Hypertens. Rep. 2008, 10, 188-193
11. Nakajima, M.; Hutchinson, H.; Fujinagam, M, et al: The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gainof-function study using gene transfer. Proc. Natl. Acad. Sci. USA 1995, 92, 10663-10667.
12. Tsuzuki, S.; Eguchi, S.; Inagami, T. Inhibition of cell proliferation and activation of protein tyrosine phosphatase mediated by angiotensin II type 2 (AT2) receptor in R3T3 cells. Biochem. Biophys. Res. Commun., 1996, 228, 825-830. (Pubitemid 26421462)
13. Tsuzuki, S.; Matoba, T.; Eguchi, S.; Inagami T. Angiotensin II type 2 receptor inhibits cell proliferation and activates tyrosine phosphatase. Hypertension, 1996, 28, 916-918. (Pubitemid 26365541)
14. Meffert, S.; Stoll, M.; Steckelings, U.M.; Bottari, S.P.; Unger, T. The angiotensin II AT2 receptor inhibits proliferation and promotes differentiation in PC12W cells. Mol. Cell Endocrinol., 1996, 122, 59-67. (Pubitemid 26328859)
15. Horiuchi, M.; Hayashida, W.; Kambe, T.; Yamada, T.; Dzau, V.J. Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogenactivated protein kinase phosphatase-1 and induces apoptosis. J. Biol. Chem., 1997, 272, 19022-19026. (Pubitemid 27318258)
16. Yamada, T.; Akishita, M.; Pollman, M.; Gibbons, G.H.; Dzau, V.J.; Horiuchi, M. Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis and antagonizes angiotensin type 1 receptor action: an in vitro gene transfer study. Life Sci., 1998, 63, PL289-PL295.
17. Wolf, G.; Wenzel, U.; Burns, K.D.; Harris, R.C.; Stahl R.A.K.; Thaiss, F. Angiotensin II activates nuclear transcription factor-B through AT1 and AT2 receptors. Kidney Int., 2002, 61, 1986-1995 (Pubitemid 34539316)
18. Ruiz-Ortega, M.; Esteban, V.; Suzuki, Y.; Ruperez, M.; Mezzano, S.; Ardiles, L.; Justo, P.; Ortiz, A.; Egidio, J. Renal expression of angiotensin type 2 (AT2) receptors during kidney damage. Kidney Int. Suppl., 2003, 86, S21-S26 (Pubitemid 37159623)
19. Bullock, G.R.; Steyaert, I.; Bulbe, G.; Carey, R.M.; Kips, J.; DePaepe, B.; Pauwels, R.; Praet, M.; Siragy, H.M.; de Gasparo, M. Distribution of type-1 and type-2 angiotensin receptors in the normal human lung and in lungs from patients with chronic obstructive pulmonary disease. Histochem. Cell Biol., 2001, 115, 117-124. (Pubitemid 32186490)
20. Henrion, D.; Kubis, N.; Lévy, BI. Physiological and pathophysiological functions of the AT2 subtype receptor of angiotensin II. Hypertension, 2001, 38, 1150-57.
21. Watanabe, T.; Barker, T.A.; Berk, B.C. Angiotensin II and the endothelium. Diverse signals and effects. Hypertension, 2005, 45, 163-69. (Pubitemid 40179951)
22. Ferrario, C.M.; Chappell, M.C. Novel angiotensin peptides. Cell Mol. Life Sci., 2004, 61, 2720-2727 (Pubitemid 40022433)
23. Guo, C.; Ju, H.; Leung, D.; Massaeli, H.; Shi, M.; Rabinovitch, M. A novel vascular smooth muscle chymase is upregulated in hypertensive rats. J. Clin. Invest., 2001, 107, 703-15. (Pubitemid 32225356)
24. Borland, J.A.; Kelsall, C.; Yacoub, M.H.; Chester, AH. Expression, localisation and function of ACE and chymase in normal and atherosclerotic human coronary arteries. Vascul. Pharmacol., 2005, 42, 99-108. (Pubitemid 40424568)
25. Bacani, C.; Frishman, W.H. Chymase: a new pharmacologic target in cardiovascular disease. Cardiol. Rev., 2006, 14, 187-193 (Pubitemid 44350510)
26. Miyazaki, M.; Takai, S. Tissue angiotensin II generating system by angiotensin-converting enzyme and chymase. J. Pharmacol. Sci., 2006, 100, 391-397 (Pubitemid 44609530)
27. Cesari, M.; Rossi, G.P.; Pessina, A.C. Biological properties of the angiotensin peptides other than angiotensin II: implications for hypertension and cardiovascular diseases. J. Hypertens., 2002, 20, 793-799 (Pubitemid 34913648)
28. Ruiz-Ortega, M.; Lorenzo, O.; Egido, J. Angiotensin III increases MCP-1 and activates NF-kappaB and AP-1 in cultured mesangial and mononuclear cells. Kidney Int., 2000, 57, 2285-2298 (Pubitemid 30340728)
29. Hamilton, T.A.; Handa, R.K.; Harding, J.W.; Wright, J.W. A role for angiotensin IV/AT4 system in mediating natiuresis in the rat. Peptides, 2001, 22, 935-944 (Pubitemid 32522971)
30. Kramar, E.A.; Harding, J.W.; Wright, J.W. Angiotensin II- and IV-induced changes in cerebral blood flow. Roles of AT1 and AT2, and AT4 receptor subtypes. Regul. Pept., 1997, 68, 131-138 (Pubitemid 27138368)
31. Clempus, R.E.; Griendling, K.K. Reactive oxygen species signaling in vascular smooth muscle cells. Cardiovasc. Res., 2006, 71, 216-225.
32. Nakashima, H.; Suzuki, H.; Ohtsu, H.; Chao, Jy.; Utsunomiya, H.; Frank, G.D.; Eguchi, S. Angiotensin II regulates vascular and endothelial dysfunction: recent topics of angiotensin II type 1 receptor signaling in the vasculature. Curr. Vasc. Pharmacol, 2006, 4, 67-78. (Pubitemid 46785183)
33. Alvarez, A.; Cerdá-Nicolás, M.; Naim, Abu.; Nabah, Y.; Mata, M.; Issekutz, AC; PanésLoob, R.R.; Sanz, M.J. Direct evidence of leukocyte adhesion in arterioles by angiotensin II. Blood, 2004, 104, 402-408 (Pubitemid 38900021)
34. Guba, M.; Steinbauer, M.; Buchner, M.; et al. Differential effects of shortterm ACE- and AT1-receptor inhibition on postischemic injury and leukocyte adherence in vivo and in vitro. Shock, 2000, 13, 190-196.
35. Piqueras, L.; Kubes, P.; Alvarez, A.; O'Connor, E.; Issekutz, A.C.; Esplugues, J.V.; Sanz, M.J. Angiotensin II induces leukocyte-endothelial cell interactions in vivo via AT(1) and AT(2) receptor-mediated P-selectin upregulation. Circulation, 2000, 102, 2118-2123
36. Pueyo, M.E.; Gonzalez, W.; Nicoletti, A.; Savoie, F.; Arnal, J.F.; Michel, J.B. Angiotensin stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress. Artherocler. Thromb. Vasc. Biol. 2000, 20, 645-651 (Pubitemid 30151676)
37. Selby, C.; Drost, E.; Lannan, S.; et al. Neutrophil retention in the lungs of patients with chronic obstructive pulmonary disease. Am. Rev. Respir. Dis., 1991, 143, 1359-1364.
38. Wolf, G.; Schneider, A.; Helmchen, U.M.; Stahl, R.A.K. AT1-receptor antagonists abolish glomerular MCP-1 expression in a model of mesangial proliferative glomerulonephritis. Exp. Nephrol, 1998, 6, 112-120 (Pubitemid 28140992)
39. Chen, X.L.; Tummala, P.E.; Olbrych, M.T.; et al: Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells. Cir. Res., 1998, 83, 952-959. (Pubitemid 28503085)
40. Wolf, G.; Ziyadeh, FN.; Thaiss, F.; et al: Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. Role of the angiotensin type 2 receptor. J. Clin. Invest, 1997, 100, 1047-1058 (Pubitemid 27386288)
41. Barnes, P.J.; Karin, M. Nuclear factor-KB - A pivotal transcriptionfactor in chronic inflammatory diseases. N. Engl. J. Med., 1997, 336, 1066-1071 (Pubitemid 27163860)
42. Tak, P.P.; Firestein, G.S. NF-KB: A key role in inflammatory diseases. J. Clin. Invest, 2001, 107, 7-11 (Pubitemid 32047405)
43. Karin, M. How NF-KB is activated: The role of the IKB kinase (IKK) complex. Oncogene, 1999, 18, 6867-6874
44. 2 receptors. Am. J. Pathol, 2001, 158, 1743-1756 (Pubitemid 32422939)
45. Nataraj, C.; Oliverio, M.I.; Mannon, R.B.; et al. Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway. J. Clin. Invest., 1999, 104, 1693-1701 (Pubitemid 30053186)
46. Hisada, Y.; Sugaya, T.; Yamanoucchi, M.; et al: Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice. J. Clin. Invest, 1999, 103, 627-635 (Pubitemid 29122415)
47. Dai, Q.; Xu, M.; Yao, M.; Sun, B. Angiotensin AT1 receptor antagonists exert anti-inflammatory effects in spontaneously hypertensive rats. Br. J. Pharmacol, 2007, 152, 1042-1048 (Pubitemid 350166045)
48. Bush, E.; Maeda, N.; Kuziel, W.A.; Dawson, T.C.; Wilcox, J.N.; DeLeon, H.; Taylor, W.R. CC chemokine receptor 2 is required for macrophage infiltration and vascular hypertrophy in angiotensin II-induced hypertension. Hypertension, 2000, 36, 360-363
49. Guo, F; Chen, X.L.; Wang, F.; Liang, X.; Sun, Y.X.; Wang, Y.J. Role of Angiotensin II Type 1 Receptor in Angiotensin II-Induced Cytokine Production in Macrophages. J. Interferon Cytokine Res., 2011 Jan 15. [Epub ahead of print]
50. Joppa, P.; Petrasova, D.; Stancak, B.; Tkacova, R. Systemic inflammation in patients with COPD and pulmonary hypertension. Chest, 2006, 130, 326-333. (Pubitemid 44266997)
51. Chaouat, A.; Savale, L.; Chouaid, C.; Tu, L.; Sztrymf, B.; Canuet, M.; Maitre, B.; Housset, B.; Brandt, C.; Le Corvoisier, P.; Weitzenblum, E.; Eddahibi, S.; Adnot, S. Role for interleukin-6 in COPD-related pulmonary hypertension. Chest, 2009, 136, 678-87.
52. Stewart, A.G.; Waterhouse, J.C.; Billings, CG.; Baylis, P.; Howard, P. Effects of angiotensin converting enzyme inhibition on sodium excretion in patients with hypoxaemic chronic obstructive pulmonary disease. Thorax, 1994, 49, 995-998. (Pubitemid 24315991)
53. Kiely, D.G.; Cargill, R.I.; Wheeldon, N.M.; Coutie, W.J.; Lipworth, B.J. Haemodynamic and endocrine effects of type 1 angiotensin II receptor blockade in patients with hypoxaemic cor pulmonale. Cardiovasc. Res., 1997, 33, 201-208. (Pubitemid 27019116)
54. Mrug, M.; Stopka, T; Julian, B.A.; Prchal, J.F.; Prchal, J.T. Angiotensin II stimulates proliferation of normal early erythroid progenitors. J. Clin. Invest, 1997, 100, 2310-2314. (Pubitemid 27500154)
55. Vlahakos, D.V.; Kosmas, E.N.; Dimopoulou, I; et al. Association between activation of the renin-angiotensin system and secondary erythrocytosis in patients with chronic obstructive pulmonary disease. Am. J. Med., 1999, 106, 158-164. (Pubitemid 29115955)
56. Vlahakos, D.V.; Marathias, K.P.; Kosmas, E.N. Losartan reduces hematocrit in patients with chronic obstructive pulmonary disease and secondary erythrocytosis. Ann. Intern. Med., 2001, 134, 426-427. (Pubitemid 32179484)
57. Andreas, S.; Herrman-Linger, C.; Raupach, T.; Luthje, L.; Fabricius, J.A.; Hruska, N; Korber, W.; Buchner, B.; Criee CP.; Hasenfuß, G.; Calverley, P. Angiotensin II blockers in obstructive pulmonary disease: a randomized controlled trial. Eur. Respir. J., 2006, 27, 972-979. (Pubitemid 44911111)
58. Ohwada, K.; Watanabe, K.; Okuyama, K.; Ohkawara, Y.; Sugaya, T.; Takayanagi, M.; Ohno, I. The involvement of type 1a angiotensin II receptors in the regulation of airway inflammation in a murine model of allergic asthma. Clin. Exp. Allergy., 2007 Nov, 37(11), 1720-7. Epub 2007 Sep 17. (Pubitemid 47609845)
59. Platten, M.; Youssef, S.; Hur, E.M.; Ho, P.P.; Han, M.H.; Lanz, T.V.; Phillips, L.K.; Goldstein, M.J.; Bhat, R.; Raine, C. Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1-and TH17-mediated autoimmunity. Proc. Natl. Acad. Sci. USA, 2009, 106, 14948-14953
60. Okunuki, Y.; Usui, Y.; Nagai, N.; Kezuka, T.; Ishida, S.; Takeuchi, M.; Goto, H. Suppression of experimental autoimmune uveitis by angiotensin II type 1 receptor blocker telmisartan. Invest. Ophthalmol. Vis. Sci., 2009, 50, 2255-2261
61. Jurewicz, M.; McDermott, D.H.; Sechler, J.M.; Tinckam, K.; Takakura, A.; Carpenter, C.B.; Milford, E.; Abdi, R. Human T and Natural Killer Cells Possess a Functional Renin-Angiotensin System: Further Mechanisms of Angiotensin II-Induced Inflammation. J. Am. Soc. Nephrol., 2007, 18, 1093-1102 (Pubitemid 46536895)
62. Cosio, M.G.; Majo, J. Inflammation of the airways and lung parenchyma in COPD: role of T cells. Chest, 2002, 121(5 Suppl), 160S-5S (Pubitemid 34497335)
63. Larche, M.; Robinson, D.S.; Kay, A.B. The role of T lymphocytes in the pathogenesis of asthma. J. Allergy Clin. Immunol., 2003, 111(3), 450-463. (Pubitemid 36337859)
64. Ruiz-Ortega, M.; Bustos, C.; Hernandez-Presa, M.A.; Lorenzo, O.; Plaza, J.J.; Egido, J. Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis. J. Immunol. 1998, 161, 430-439 (Pubitemid 28285552)
65. Lapteva, N.; Nieda, M.; Ando, Y.; Ide, K.; Hatta-Ohashi, Y.; Dymshits, G.; Ishikawa, Y.; Juji, T.; Tokunaga, K. Expression of renin-angiotensin system genes in immature and mature dendritic cells identified using human cDNA microarray. Biochem. Biophys. Res. Commun., 2001, 285, 1059-1065 (Pubitemid 32918045)
66. Lapteva, N.; Ide, K.; Nieda, M.; Ando, Y.; Hatta-Ohashi, Y.; Minami, M.; Dymshits, G.; Egawa, K.; Juji, T.; Tokunaga, K. Activation and suppression of renin-angiotensin system in human dendritic cells. Biochem. Biophys. Res. Commun., 2002, 296, 194-200 (Pubitemid 35002078)
67. Nahmod, K.A.; Vermeulen, M.E.; Raiden, S.; Salamone, G.; Gamberale, R.; Fernandez-Calotti, P.; Alvarez, A.; Nahmod, V.; Giordano, M.; Geffner, J.R. Control of dendritic cell differentiation by angiotensin II. FASEB J., 2003, 17, 491-493
68. Remuzzi, G.; Zoja, C.; Gagliardini, E.; Corna, D.; Abbate, M.; Benigni, A. Combining an antiproteinuric approach with mycophenolate mofetil fully suppresses progressive nephropathy of experimental animals. J. Am. Soc. Nephrol., 1999, 10, 1542-1549 (Pubitemid 29297529)
69. Wu, K.; Zhou, T.; Sun, G.; Wang, W.; Zhang, Y.; Hao, L.; Chen, N. Valsartan inhibited the accumulation of dendritic cells in rat fibrotic renal tissue. Cell. Mol. Immunol. 2006, 3, 213-220
70. Zanini, A.; Chetta, A.; Saetta, M.; Baraldo, S.; D'Ippolito, R.; Castagnaro, A.; Neri, M.; Olivieri, D. Chymase-positive mast cells play a role in the vascular component of airway remodeling in asthma. J. Allergy. Clin. Immunol., 2007, 120, 329-33. (Pubitemid 47102382)
71. Berger, P.; Laurent, F.; Begueret, H.; Perot, V.; Rouiller, R.; Raherison, C.; Molimard. M.; Marthan, R.; Tunon-de-Lara, J.M. Structure and function of small airways in smokers: relationship between air trapping at CT and airway inflammation. Radiology, 2003, 228, 85-94. (Pubitemid 36736073)
72. Ji, Y.; Liu, J.; Wang, Z.; Liu, N. Angiotensin II induces inflammatory response partly via toll-like receptor 4-dependent signaling pathway in vascular smooth muscle cells. Cell Physiol. Biochem., 2009, 23, 265-276
73. Lv, J.; Jia, R.; Yang, D.; Zhu, J.; Ding, G. Candesartan attenuates Angiotensin II induced mesangial cell apoptosis via TLR4/MyD88 pathway. Biochem. Biophys. Res. Commun., 2009, 380, 81-86
74. Yang, J.; Jiang, H.; Ding, J.W.; Chen, LH.; Li, S.; Zhang, X.D. Valsartan preconditioning protects against myocardial ischemia-reperfusion injury through TLR4/NF-kappaB signaling pathway. Mol. Cell Biochem., 2009, 330, 39-46
75. Parkos, C.A.; Allen, R.A.; Cochrane, C.G.; Jesaitis A.J. Purified cytochrome b from human granulocyte plasma membrane is comprised of two polypeptides with relative molecular weights of 91,000 and 22,000. J. Clin. Invest., 1987, 80, 732-742 (Pubitemid 18003944)
76. Jones, S.A.; Hancock, J.T.; Jones, O.T.; Neubauer, A.; Topley, N. The expression of NADPH oxidase components in human glomerular mesangial cells: detection of protein and mRNA for p47phox, p67phox, and p22phox. J. Am. Soc. Nephrol., 1995 Jan, 5(7), 1483-1491.
77. Klug, D.; Rabani, J.; Fridovich, I. A direct demonstration of the catalytic action of superoxide dismutase through the use of pulse radiolysis. J. Biol. Chem., 1972, 247, 4839-4842.
78. 2. Arch. Biochem. Biophys., 1981, 210, 505-516. (Pubitemid 12243701)
79. Janssen-Heininger, Y.M.; Poynter, M.E.; Baeuerle, P.A. Recent advances towards understanding redox mechanisms in the activation of nuclear factor kB. Free Radic. Biol. Med., 2000, 28, 1317-1327. (Pubitemid 30621476)
80. Hildeman, D.A.; Mitchell, T.; Aronow, B.; Wojciechowski, S.; Kappler, J.; Marrack, P. Control of Bcl-2 expression by reactive oxygen species. Proc. Natl. Acad. Sci. U S A., 2003, 9;100(25):15035-15040. Epub 2003 Dec 1. (Pubitemid 37518012)
81. 2 in Angiotensin II-Induced Vascular Hypertrophy. Hypertension, 1998, 32, 488-495. (Pubitemid 28429138)
82. Wolf, G. Role of reactive oxygen species in angiotensin II-mediated renal growth, differentiation, and apoptosis. Antioxid. Redox. Signal, 2005, Sep-Oct, 7(9-10), 1337-1345 (Pubitemid 41232531)
83. - in vascular smooth muscle cells. Circ. Res., 1995, 77, 29-36.
84. 2. J. Biol. Chem., 1996, 271, 4138-4142.
85. Ushio-Fukai, M.; Alexander, R.W.; Akers, M.; Griendling, K.K. p38 MAP kinase is a critical component of the redox-sensitive signaling pathways by angiotensin II: role in vascular smooth muscle cell hypertrophy. J. Biol. Chem., 1998, 273, 15022-15029. (Pubitemid 28272796)
86. Rao, G.N.; Berk, B.C. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ. Res., 1992, 70, 593-599.
87. Rao, G.N.; Lassegue, B.; Griendling, K.K.; Alexander, R.W. Hydrogen peroxide stimulates transcription of c-jun in vascular smooth muscle cells: role of arachidonic acid. Oncogene, 1993, 8, 2759-2764. (Pubitemid 23279104)
88. Rao, G.N.; Lassegue, B.; Griendling, K.K.; Alexander, R.W.; Berk, B.C. Hydrogen peroxide-induced c-fos expression is mediated by arachidonic acid release: Role of protein kinase C. Nucleic Acids Res., 1993, 21, 1259-1263. (Pubitemid 23155625)
89. Laurell, C.B.; Eriksson, S. The electrophoretic alpha-1 globulin pattern of serum in alpha-1 antitrypsin deficiency. Scand. J. Clin. Lab. Invest., 1963; 15, 132-140.
90. Shapiro, S.D. Elastolytic metalloproteinases produced by human mononuclear phagocytes. Potential roles in destructive lung disease. Am. J. Respir. Crit. Care Med., 1994, 150, S160-4. (Pubitemid 24364342)
91. Szmitko, P.E.; Wang, C.H.; Weisel, R.D.; Jeffries, G.A.; Anderson, T.J.; Verma, S. Biomarkers of vascular disease linking inflammation to endothelial activation. Part II. Circulation, 2003, 108, 2041-2048. (Pubitemid 37337575)
92. Libby, P.; Ridker, P.M.; Maseri, A. Inflammation and atherosclerosis. Circulation, 2002, 105, 1135-1143. (Pubitemid 34212626)
93. Cipollone, F.; Fazia, M.; Iezzi, A.; Pini, B.; Cuccurullo, C.; Zucchelli, M.; de Cesare, D.; Ucchino, S.; Spigonardo, F.; De Luca, M.; Muraro, R.; Bei, R.; Bucci, M.; Cuccurullo, F.; Mezzetti, A. Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prosta-glandin E2-dependent matrix metalloproteinase activity. Circulation, 2004; 109: 1482-1488. (Pubitemid 38420175)
94. Kohlstedt, K.; Busse, R.; Fleming, I. Signaling via the angiotensin converting enzyme enhances the expression of cyclooxygenase-2 in endothelial cells. Hypertension, 2005, 45, 126-132. (Pubitemid 40066426)
95. Wintroub, B.U.; Klickstein, L.B.; Watt, K.W.K. A human neutrophil dependent pathway for generation of angiotensin II: purification of the product and identification as angiotensin II. J. Clin. Invest., 1981, 68, 484.
96. Reilly, C.F.; Tewksbury, D.A.; Schechter, N.M.; Travis, J. Rapid conversion of angiotensin I to angiotensin II by neutrophil and mast cell proteinases. J. Biol. Chem., 1982, 257, 8619.
97. Klickstein, L.B.; Kaempfer, C.E.; Wintroub, B.U. The granulocyte- angiotensin system. Angiotensin I-converting activity of cathepsin G. J. Biol. Chem., 1982, 257, 15042-15046. (Pubitemid 13164853)
98. Owen, C.A.; Campbell, M.A.; Boukedes, S.S.; Stockley, R.A.; Campbell, E.J. A discrete subpopulation of human monocytes expresses a neutrophillike pro-inflammatory (P) phenotype. Am. J. Physiol., 1994, 267, L775.
99. Campbell, E.J.; Silverman, E.K.; Campbell, M.A. Elastase and cathepsin G of human monocytes: quantification of cellular content, release in response to stimuli, and heterogeneity in elastase-mediated proteolytic activity. J. Immunol., 1989, 143, 2961-2968. (Pubitemid 19281845)
100. Owen, C.A.; Campbell, M.A.; Boukedes, S.S.; Campbell, E.J. Inducible binding of cathepsin G to the cell surface of neutrophils: a mechanism for mediating extracellular proteolytic activity of cathepsin G. J. Immunol., 1995, 155, 5803-5810
101. Owen, C.A.; Campbell, M.A.; Sannes, P.L.; Boukedes, S.S.; Campbell, E.J. Cell-surface-bound elastase and cathepsin G on human neutrophils: a novel, non-oxidative mechanism by which neutrophils focus and preserve catalytic activity of serine proteinases. J. Cell Biol., 1995, 131, 775-789
102. Owen, C.A.; Campbell, E.J. Angiotensin II Generation at the Cell Surface of Activated Neutrophils: Novel Cathepsin G-Mediated Catalytic Activity That Is Resistant to Inhibition. J Immunol., 1998, 160, 1436-1443. (Pubitemid 28093445)
103. Brown, A.J.; Nally, J.E. Hydrocortisone abolishes the angiotensin II-mediated potentiation of endothelin-1 in bovine bronchi. Clin. Sci. (Lond)., 2001, Jan, 100(1), 19-23. (Pubitemid 32057803)
104. Nally, J.E.; Clayton, R.A.; Wakelam, M.J.; Thomson, N.C.; McGrath, J.C. Angiotensin II enhances responses to endothelin-1 in bovine bronchial smooth muscle. Pulm. Pharmacol., 1994, 7(6), 409-13.
105. Pitt, C.M.; Nally, J.E. Angiotensin II-mediated potentiation of endothelin-1-evoked bronchial contractions: a role for leukotrienes? Pulm. Pharmacol. Ther., 1999, 12(1), 7-12. (Pubitemid 29201615)
106. Rao, G.N.; Lassegue, B.; Alexander, R.W.; Griendling, K.K. Angiotensin II stimulates phosphorylation of high-molecular-mass cytosolic phospholipase A2 in vascular smooth-muscle cells. Biochem. J., 1994, 299, 197-201 (Pubitemid 24106309)
107. Gijon, M.A.; Leslie, C.C. Regulation of arachidonic acid release and cytosolic phospholipase A2 activation. J. Leukoc. Biol., 1999, 65, 330-336 (Pubitemid 29109704)
108. Pollock, D.M. Endothelin, angiotensin, and oxidative stress in hypertension. Hypertension, 2005, 45, 477-480. (Pubitemid 40411242)
109. Yanagisawa, M.; Kurihara, H.; Kimura, S. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature, 1988, 332, 411-415. (Pubitemid 18090241)
110. Advenier, C.; Sarria, B.; Naline, E.; Puybasset, L.; Lagente, V. Contractile activity of three endothelins (ET-1, ET-2 and ET-3) on the human isolated bronchus. Br. J. Pharmacol, 1990, 100, 168-172. (Pubitemid 20161449)
111. Teder, P.; Noble, PW. A Cytokine Reborn? Endothelin-1 in Pulmonary Inflammation and Fibrosis. Am. J. Respir. Cell Mol. Biol, 2000, 23, 7-10. (Pubitemid 30597089)
112. McCarron, R.; Wang, L.; Stanimirovic, D.; Spatz, M. Endothelin induction of adhesion molecule expression on human brain microvascular endothelial cells. Neurosc. Letters, 1993, 156, 31-34. (Pubitemid 23214717)
113. Helset, E.; Ytrehus, K.; Tveita, T.; Kjaeve, J.; Jorgensen, L. Endothelin-1 causes accumulation of leucocytes in the pulmonary circulation. Circ. Shock, 1994, 44, 201-209.
114. Lopez Farre, A.; Riesco, A.; Espinosa, G.; Digiuni, E.; Cernadas, M.; Alvarez, V.; Monton, M.; Rivas, F.; Gallego, M.; Egido, J.; Casado, S.; Caramelo, C. Effect of endothelin-1 on neutrophil adhesion to endothelial cells and perfused heart. Circulation, 1993, 88, 1166-1171. (Pubitemid 23264035)
115. Chen, Y.; Hanaoka, M.; Droma, Y; Chen, P.; Voelkel, N.F.; Kubo, K. Endothelin-1 receptor antagonists prevent the development of pulmonary emphysema in rats. Eur. Respir. J., 2010, 35(4), 904-912. Epub 2009 Nov 6.
116. Duerrschmidt, N.; Wippich, N.; Goettsch, W. Endothelin-1 induces NAD(P)H oxidase in human endothelial cells. Biochem. Biophys. Res. Commun., 2000, 269, 713-717. (Pubitemid 30440367)
117. Myou, S.; Fujimura, M.; Kurashima, K.; Tachibana, H.; Watanabe, K.; Hirose, T. Type 1 angiotensin II receptor antagonism reduces antigeninduced airway reactions. Am. J. Respir. Crit. Care Med., 2000, 162(1), 45-49. (Pubitemid 30469796)
118. Millar, E. A.; Nally, J. E.; Thomson, N. C. Angiotensin II potentiates methacholine-induced bronchoconstriction in human airway both in vitro and in vivo. Eur. Respir. J., 1995, 8, 1838-1841.
119. Rennard, S.I. Inflammation and repair processes in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med., 1999, 160, S12-6.
120. Elias, J.A.; Zhu, Z.; Chupp, G.; Homer, R.J. Airway remodeling in asthma. J. Clin. Invest, 1999, 104, 1001-1006.
121. Vignola, A.M.; Chanez, P.; Chiappara, G.; Merendino, A.; Pace, E.; Rizzo, A.; la Rocca, A.M.; Bellia, V.; Bonsignore, G.; Bousquet, J. Transforming growth factor-β expression in mucosal biopsies in asthma and chronic bronchitis. Am. J. Respir. Crit. Care Med., 1997, 156, 591-599. (Pubitemid 27352000)
122. Takizawa, H.; Tanaka, M.; Takami, K.; Ohtoshi, T.; Ito, K.; Satoh, M.; Okada, Y; Yamasawa, F.; Nakahara, K.; Umeda, A. Increased expression of transforming growth factor-beta1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD). Am. J. Respir. Crit. Care Med, 2001, 163, 1476-1483. (Pubitemid 32506619)
123. Broekelmann, T.J.; Limper, A.H.; Colby, T.V.; McDonald, J.A. Transforming growth factor β1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc. Natl. Acad. Sci. USA, 1991, 88, 6642-6646. (Pubitemid 21915005)
124. Khalil, N; O'Connor, R.N.; Flanders, K.C.; Unruh, H. TGF-β1, but not TGF-β2 or TGF-β3, is differentially present in epithelial cells of advanced pulmonary fibrosis: an immunohistochemical study. Am. J. Respir. Cell Mol Biol, 1996, 14, 131-138. (Pubitemid 126441385)
125. Lee, CG.; Homer, R.J.; Zhu, Z.; Lanone, S.; Wang, X.; Koteliansky, V.; Shipley, J.M.; Gotwals, P.; Noble, P.; Chen, Q.; Senior, RM.; Elias, J.A. Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor β1. J. Exp. Med, 2001, 194, 809-821. (Pubitemid 32983016)
126. Anderson, P.W.; Zhang, X. Y; Tian, J.; Correale, J.D.; Xi, X.P; Yang, D.; Graf, K.; Law, R.E.; Hsueh, W.A. Insulin and angiotensin II are additive in stimulating TGF-beta 1 and matrix mRNAs in mesangial cells. Kidney Int., 1996, 50, 745-753. (Pubitemid 26302661)
127. Kagami, S.; Border, W.A.; Miller, D.E.; Noble, N.A. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J. Clin. Invest, 1994, 93, 2431-2437. (Pubitemid 24177156)
128. Saito, K.; Ishizaka, N; Aizawa, T.; Sata, M.; Iso-o, N; Noiri, E.; Mori, I; Ohno, M.; Nagai, R. Iron chelation and a free radical scavenger suppress angiotensin II-induced upregulation of TGF-beta1 in the heart. Am. J. Physiol. Heart Circ. Physiol, 2005, 288, 1836-1843. Epub 2004 Nov 18.
129. Liu, J.; Gong, H.; Zhang, Z.T.; Wang, Y Effect of angiotensin II and angiotensin II type 1 receptor antagonist on the proliferation, contraction and collagen synthesis in rat hepatic stellate cells. Chin. Med. J., 2008, 121, 161-165. (Pubitemid 351247891)
130. Otsuka, M.; Takahashi, H.; Shiratori, M.; Chiba, H.; Abe, S. Reduction of bleomycin induced lung fibrosis by candesartan cilexetil, an angiotensin II type 1 receptor antagonist. Thorax, 2004, 59, 31-38. (Pubitemid 38067969)
131. Li, X.; Rayford, H.; Uhal, B.D. Essential roles for angiotensin receptor AT1a in bleomycin-induced apoptosis and lung fibrosis in mice. Am. J. Pathol, 2003, 163, 2523-2530. (Pubitemid 37466493)
132. Wang, R.; Ibarra-Sunga, O.; Verlinkski, L.; Pick, R.; Uhal B.D. Abrogation of bleomycin-induced epithelial apoptosis and lung fibrosis by captopril or by a caspase inhibitor. Am. J. Physiol. Lung Cell. Mol Physiol, 2000, 279, L143-L151. (Pubitemid 30619534)
133. Marshall, R.P; McAnulty, R.J.; Laurent, G.F. Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor. Am. J. Respir. Crit. Care Med, 2006, 161, 1999-2004.
134. Renzoni, E.A.; Abraham. D.J.; Howat. S.; Shi-Wen, X.; Sestini, P.; Bou-Gharios, G.; Wells, A.U.; Veeraraghavan, S.; Nicholson, A.G.; Denton, C.P; Leask, A.; Pearson, J.D.; Black, CM.; Welsh, K.I.; deBois, RM. Gene expression profiling reveals novel TGFβ targets in adult lung fibroblasts. Respir. Res., 2004, 5, 24.
135. Martin, MM.; Buckenberger, J.A.; Jiang, J.; Malana, G.E.; Knoell, D.L.; Feldman, D.S.; Elton, TS. TGF-beta1 stimulates human AT1 receptor expression in lung fibroblasts by cross talk between the Smad, p38 MAPK, JNK, and PI3K signaling pathways. Am. J. Physiol. Lung Cell. Mol Physiol, 2007, 293, 790-799. Epub 2007 Jun 29.
136. Du, Y.C.; Xu, J. Y; Zhang S.J. Effects of angiotensin II receptor antagonist on expression of collagen III, collagen V, and transforming growth factor β1 in the airway walls of sensitized rats. Chin. Med. J., 2004, 117, 908-912.
137. Chanez. P.; Vignola, M.; Stenger, R.; Vic, P.; Michel, F.B.; Bousquet, J. Platelet-derived growth factor in asthma. Allergy, 1995, 50, 878-883.
138. Wang, T.; Yin, K.S.; Liu, K.Y; Lu, G.J.; Li, Y.H.; Chen, J.D. Effect of valsartan on the expression of angiotensin II receptors in the lung of chronic antigen exposure rats. Chin. Med. J. (Engl), 2008, 121, 2312-2319.
139. Dzau, V.J.; Gnecchi, M.; Pachori, A.S. Therapeutic potential of endothelial progenitor cells in cardiovascular diseases. Hypertension, 2005; 46: 7-18. (Pubitemid 40946479)
140. Kanazawa, H.; Hirata, K.; Yoshikawa, J. Involvement of vascular endothelial growth factor in exercise induced bronchoconstriction in asthmatic patients. Thorax, 2002, 57, 885-888. (Pubitemid 35178614)
141. Dzau, Q.; Ishibashi, M.; Hiasa, K. Essential role of vascular endothelial growth factor in angiotensin II-induced vascular inflammation and remodeling. Hypertension, 2004, 44, 264-270. (Pubitemid 39172204)
142. Morishita, R. Is vascular endothelial growth factor a missing link between hypertension and inflammation? Hypertension, 2004, 44, 253-257.
143. Tashiro, K.; Hagiya, M.; Nishizawa, T.; Seki, T.; Shimonishi, M.; Shimizu, S.; Nakamura, T. Deduced primary structure of rat hepatocyte growth factor and expression of the mRNA in rat tissues. Proc. Natl. Acad. Sci. USA, 1990, 87, 3200-3204.
144. Ueki, T; Kaneda, Y; Tsutsui, H.; Nakanishi, K.; Sawa, Y; Morishita, R.; Matsumoto, K.; Nakamura, T; Takahashi, H.; Okamoto, E. Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat. Med, 1999, 5, 226-230. (Pubitemid 29068532)
145. Mizuno, S.; Kurosawa, T; Matsumoto, K.; Mizuno-Horikawa, Y; Okamoto, M.; Nakamura, T. Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mice model of chronic renal disease. J. Clin Invest, 1998, 101, 1827-1834. (Pubitemid 28226100)
146. Taniyama, Y; Morishita, R.; Nakagami, H.; Moriguchi, A.; Sakonjo, H.; Shokei-Kim.; Matsumoto, K.; Nakamura, T.; Higaki, J.; Ogihara, T. Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamsters. Circulation, 2000, 102, 246-252. (Pubitemid 30451784)
147. Ito, W.; Kanehiro, A.; Matsumoto, K.; Hirano, A.; Ono, K.; Maruyama, H.; Kataoka, M.; Nakamura, T; Gelfand, E.W.; Tanimoto, M. Hepatocyte growth factor attenuates airway hyperresponsiveness, inflammation, and remodeling. Am. J. Respir. Cell. Mol Biol, 2005, 32, 268-280. Epub 2004 Dec 30. (Pubitemid 40478302)
148. Luan, B.; Song, L. Effect of valsatan on hepatocyte growth factor in the airways of asthmatic rats. Zhongguo Dang. Dai. Er. Ke. Za. Zhi., 2006, 8, 482-485. (Pubitemid 46020217)
149. Rigat, B.; Hubert, C.; Corvol, P.; Soubrier, F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res., 1992, 20, 1433.
150. Montgomery, H.; Clarkson, P.; Barnard, M.; Bell, J.; Brynes, A.; Dollery, C.; Hajnal, J.; Hemingway, H.; Mercer, D.; Jarman, P.; Marshall, R.; Prasad, K.; Rayson, M.; Saeed, N; Talmud, P.; Thomas, L.; Jubb, M.; World, M.; Humphries, S. Angiotensin-converting-enzyme gene insertion/deletion polymorphism and response to physical training. Lancet, 1999, 353, 541-545. (Pubitemid 29078424)
151. Chagani, T; Pare, P.D.; Zhu, S. Prevalence of tumor necrosis factor-alpha and angiotensin converting enzyme polymorphisms in mild/moderate and fatal/near-fatal asthma. Am. J. Respir Crit. Care Med, 1999, 160, 278-82. (Pubitemid 29326100)
152. Rigat, B.; Hubert, C.; Alhenc-Gelas, F; Cambien, F; Corvol, P.; Soubrier, F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest, 1990, 86, 1343-1346. (Pubitemid 20370444)
153. Uçar, G.; Yildirim, Z.; Ataol, E.; Erdogan, Y; Biber, C. Serum angiotensin converting enzyme activity in pulmonary diseases: correlation with lung function parameters. Life Sci., 1997, 61, 1075-1082. (Pubitemid 27371347)
154. Brice, E.A.; Friedlander, W.; Bateman, E.D.; Kirsch, R.E. Serum angiotensin-onverting enzyme activity, concentration, and specific activity in granulomatous interstitial lung disease, tuberculosis, and COPD. Chest, 1995, 107, 706-710.
155. Busquets, X.; MacFarlane, N.G.; Heine-Suñer, D.; Morlá, M.; Torres-Juan, L.; Iglesias, A.; Lladó, J.; Sauleda, J.; Agustí, A.G. Angiotensin-convertingenzyme gene polymorphisms, smoking and chronic obstructive pulmonary disease. Int. J. Chron. Obstruct. Pulmon. Dis., 2007, 2, 329-334. (Pubitemid 350110906)
156. van Suylen, R.J.; Wouters, E.F.; Pennings, H.J.; Cheriex, E.C.; van Pol, P.E.; Ambergen, A.W.; Vermelis, A.M.; Daemen, M.J. The DD genotype of the angiotensin converting enzyme gene is negatively associated with right ventricular hypertrophy in male patients with chronic obstructive pulmonary disease. Am. J. Respi.r Crit. Care Med., 1999, 159, 1791-5. (Pubitemid 29275044)
157. Hopkinson, N.S.; Nickol, A.H.; Payne, J.; Hawe, E.; Man, W.D.; Moxham, J.; Montgomery. H.; Polkey, M.I. Angiotensin converting enzyme genotype and strength in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med., 2004, 170, 395-399. (Pubitemid 39214613)
158. Kanazawa, H.; Otsuka, T.; Hirata, K.; Yoshikawa, J. Association between the angiotensin-converting enzyme gene polymorphisms and tissue oxygenation during exercise in patients with COPD. Chest, 2002, 121, 697-701. (Pubitemid 34251430)
159. Kanazawa, H.; Hirata, K.; Yoshikawa, J. Effects of captopril administration on pulmonary haemodynamics and tissue oxygenation during exercise in ACE gene subtypes in patients with COPD: a preliminary study. Thorax, 2003, 58, 629-631. (Pubitemid 36808136)
160. Morrell, N.W.; Atochina, E.N.; Morris, K.G.; Danilov, S.M.; Stenmark, K.R. Angiotensin converting enzyme expression is increased in small pulmonary arteries of rats with hypoxia-induced pulmonary hypertension. J. Clin. Invest., 1995, 96, 1823-1833.
161. Kanazawa, H.; Okamoto, T.; Hirata, K.; Yoshikawa, J. Deletion Polymorphisms in the Angiotensin Converting Enzyme Gene Are Associated with Pulmonary Hypertension Evoked by Exercise Challenge in Patients with Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med., 2000, 162, 1235-1238
162. Kanazawa, H.; Hirata, K.; Yoshikawa, J. Influence of oxygen administration on pulmonary haemodynamics and tissue oxygenation during exercise in COPD patients with different ACE genotypes. Clin. Physiol. Funct. Imaging, 2003, 23, 332-336 (Pubitemid 37455610)
163. Zhang, X.; Wang, C.; Dai, H.; Lin, Y.; Zhang, J. Association between angiotensin-converting enzyme gene polymorphisms and exercise performance in patients with COPD. Respirology, 2008, 13, 683-688 (Pubitemid 351977595)
164. Di Marco, F.; Guazzi, M.; Vicenzi, M.; Santus, P.; Cazzola, M.; Pappalettera, M.; Castellotti, P.; Centanni, S. Effect of enalapril on exercise cardiopulmonary performance in chronic obstructive pulmonary disease: A pilot study. Pulm. Pharmacol. Ther., 2010, 23, 159-164.
165. Tkacova, R.; Joppa, P. Angiotensin-converting enzyme genotype and C-reactive protein in patients with COPD. Eur. Respir. J., 2007, 29, 816-817. (Pubitemid 46554634)
166. Fliser, D.; Buchholz, K.; Haller, H. Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation. Circulation, 2004, 110, 1103-1107. (Pubitemid 39319009)
167. Ahsan, A.; Ram, R.; Baig, M.A.; Pasha, M.A. ACE I allele and eNOS G allele crosstalk may have a role in chronic obstructive pulmonary disease. Clin. Biochem., 2004, 37, 1037-1040 (Pubitemid 39388667)
168. Zhang, Y.G.; Li, X.B.; Zhang, J.; Huang, J.; He, C.; Tian, C.; Deng, Y.; Wan, H.; Shrestha, D.; Yang, Y.Y.; Fan, H. The I/D polymorphism of angiotensin-converting enzyme gene and asthma risk: a meta-analysis. Allergy, 2011, 66, 197-205
169. Gullestad, L.; Aukrust, P.; Ueland, T.; Espevik, T.; Yee, G.; Vagelos, R.; Froland, S.S.; Fowler, M. Effect of high-versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure. Journal of the American College of Cardiology, 1999, 34, 2061-2067. (Pubitemid 30002665)
170. Alkharfy, K.M.; Kellum, J.A.; Matzke, G.R. Unintended immunomodulation: part II. Effects of pharmacological agents on cytokine activity. Shock, 2000, 13, 346-360.
171. Skerrett, S.J.; Park, D.R. Anti-inflammatory treatment of acute and chronic pneumonia. Seminars in Respiratory Infections, 2001, 16, 76-84. (Pubitemid 32275127)
172. Mancini, G.B.; Etminan, M.; Zhang, B.; Levesque, L.E.; FitzGerald, J.M.; Brophy, J.M. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease. J. Am. Coll. Cardiol., 2006, 47, 2554-2560. (Pubitemid 43866389)
173. Mortensen, E.M.; Copeland, L.A.; Pugh, M.J.; Restrepo, M.I.; de Molina, R.M.; Nakashima, B.; Anzueto, A. Impact of statins and ACE inhibitors on mortality after COPD exacerbations. Respir. Res., 2009, 3, 10-45
174. Marshall, R.P.; Webb, S.; Bellingan, G.J.; Montgomery, H.E.; Chaudhari, B.; McAnulty, R.J.; Humphries, S.E.; Hill, M.R.; Laurent, G.J. Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med., 2002, 166, 646-650. (Pubitemid 34971844)
175. Jerng, J.S.; Yu, C.J.; Wang, H.C.; Chen, K.Y.; Cheng, S.L.; Yang, P.C. Polymorphism of the angiotensin-converting enzyme gene affects the outcome of acute respiratory distress syndrome. Crit. Care Med., 2006, 34, 1001-1006.
176. Tipnis, S.R.; Hooper, N.M.; Hyde, R.; Karran, E.; Christie, G. Turner, A.J. A human homolog of angiotensin-converting enzyme: Cloning and functional expression as a captopril-insensitive carboxypeptidase. J. Biol. Chem., 2000, 275, 33238-33243.
177. Douglas, G.C.; O'Bryan, M.K.; Hedger, M.P.; Lee, D.K.; Yarski, M.A.; Smith, A.I. The novel angiotensin-converting enzyme (ACE) homolog, ACE2, is selectively expressed by adult Leydig cells of the testis. Endocrinology, 2000, 145, 4703-4711. (Pubitemid 39281464)
178. Santos, R.A.; Frezard, F.; Ferreira, A.J. Angiotensin-(1-7): Blood, heart, and blood vessels. Curr. Med. Chem. Cardiovasc. Hematol. Agents, 2005, 3, 383 - 391.
179. Imai, Y.; Kuba, K.; Rao, S.; Huan, Y.; Guo, F.; Guan, B.; Yang, P.; Sarao, R.; Wada, T.; Leong-Poi, H.; Crackower, M.A.; Fukamizu, A.; Hui, C.C.; Hein, L.; Uhlig, S.; Slutsky, A.S.; Jiang, C.; Penninger, J.M. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature, 2005, 436, 112 - 116. (Pubitemid 40966195)
180. Ferreira, A.J.; Shenoy, V.; Yamazato, Y.; Sriramula, S.; Francis, J.; Yuan, L.; Castellano, R.K.; Ostrov, D.A.; Oh, S.P.; Katovich, M.J.; Raizada, M.K. Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension. Am. J. Respir. Crit. Care. Med., 2009, 179, 1048-1054
181. Yamazato, Y.; Ferreira, A.J.; Hong, K.H.; Sriramula, S.; Francis, J.; Yamazato, M.; Yuan, L.; Bradford, C.N.; Shenoy, V.; Oh, S.P.; Katovich, M.J.; Raizada, M.K. Prevention of pulmonary hypertension by Angiotensin-converting enzyme 2 gene transfer. Hypertension, 2009, 54, 365-371.
182. Zhang, R.; Wu, Y.; Zhao, M.; Liu, C.; Zhou, L.; Shen, S. Role of HIF-1alpha in the regulation ACE and ACE2 expression in hypoxic human pulmonary artery smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol., 2009, 297, 631-640
183. Li, W.; Moore, M.J.; Vasilieva, N.; Sui, J.; Wong, S.K.; Berne, M.A.; Somasundaran, M.; Sullivan, J.L.; Luzuriaga, K.; Greenough, T.C.; Choe, H.; Farzan, M.; Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature, 2003, 426, 450-454. (Pubitemid 37490132)
184. Kuba, K.; Imai, Y.; Rao, S.; Gao, H.; Guo, F.; Guan, B.; Huan, Y.; Yang, P.; Zhang, Y.; Deng, W.; Bao, L.; Zhang, B.; Liu, G.; Wang, Z.; Chappell, M.; Liu, Y.; Zheng, D.; Leibbrandt, A.; Wada, T.; Slutsky, A.S.; Liu, D.; Qin, C.; Jiang, C.; Penninger, J.M. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat. Med., 2005, 11, 875-879. (Pubitemid 41161120)